These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3855384)

  • 21. Mitoguazone in advanced squamous cell carcinoma of head and neck origin: a phase II trial of the Southeastern Cancer Study Group.
    Luedke DW; Maddox W; Birch R; Velez-Garcia E; Schleuter J
    Cancer Treat Rep; 1986 Apr; 70(4):529-30. PubMed ID: 3698048
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of advanced head and neck carcinoma with synchronous irradiation and methotrexate.
    Pointon RC; Askill CS; Hunter RD; Wilkinson PM
    Cancer Treat Rep; 1981; 65 Suppl 1():145-8. PubMed ID: 7326659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advances in paclitaxel-containing chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck.
    Shin DM; Glisson BS; Khuri FR; Ginsberg L; Lawhorn K; Hong WK; Lippman SM
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-33-S19-37. PubMed ID: 9427263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II evaluation of diaziquone in recurrent head and neck cancer.
    Kish JA; Ensley J; Al-Sarraf M
    Cancer Treat Rep; 1986 May; 70(5):671-2. PubMed ID: 3708616
    [No Abstract]   [Full Text] [Related]  

  • 25. Phase II ftorafur therapy in previously treated squamous cell cancers of the head and neck.
    Campbell M; Al-Sarraf M
    Cancer Treat Rep; 1980; 64(4-5):713-5. PubMed ID: 6775805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. A long-term analysis for the Illinois Cancer Center.
    Athanasiadis I; Taylor S; Vokes EE; Pelzer HJ; Rademaker A; Mittal BB; Ganzenko N; Blough R; Lester EP; Kies MS
    Cancer; 1997 Feb; 79(3):588-94. PubMed ID: 9028372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II trial of tiazofurin in recurrent squamous cell carcinoma of the head and neck.
    Dimery IW; Neidhart JA; McCarthy K; Krakoff IH; Hong WK
    Cancer Treat Rep; 1987 Apr; 71(4):425-6. PubMed ID: 3548960
    [No Abstract]   [Full Text] [Related]  

  • 28. The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT).
    Suntharalingam M; Jaboin J; Taylor R; Wolf J; Banglore M; Van Echo D; Ord R
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):2-7. PubMed ID: 15726515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II trial of epirubicin in gastric cancer.
    Scarffe JH; Kenny JB; Johnson RJ; Owens SE; Giles GR; Leveson SH; Maley WV
    Cancer Treat Rep; 1985 Nov; 69(11):1275-7. PubMed ID: 3867402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results.
    Hitt R; Hornedo J; Colomer R; Mendiola C; Brandariz A; Sevilla E; Alvarez-Vicent J; Cortés-Funes H
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):50-4. PubMed ID: 8643971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An oriented phase II trial of THP-adriamycin in breast carcinoma.
    Mathé G; Umezawa H; Oka S; Misset JL; Brienza S; de Vassal F; Musset M; Ribaud P; Tapiero H
    Biomed Pharmacother; 1986; 40(10):376-9. PubMed ID: 3580506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase II trial of weekly 4-epi-doxorubicin (epirubicin) in squamous cell carcinoma of the head and neck.
    Bertetto O; Dongiovanni V; Clerico M; Calciati A
    Tumori; 1987 Feb; 73(1):65-7. PubMed ID: 3469806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group trial (PA390).
    Forastiere AA; Shank D; Neuberg D; Taylor SG; DeConti RC; Adams G
    Cancer; 1998 Jun; 82(11):2270-4. PubMed ID: 9610709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II evaluation of mitolactol in squamous cell carcinoma of the head and neck: a Southeastern Cancer Study Group Trial.
    McHale MS; Velez-Garcia E; Nelson O; Williams SD; Maddox W; Birch R
    Cancer Treat Rep; 1986 Jul; 70(7):925-6. PubMed ID: 3521849
    [No Abstract]   [Full Text] [Related]  

  • 36. Phase II trial of pyrazofurin in advanced head and neck cancer.
    Cheng E; Currie V; Wittes RE
    Cancer Treat Rep; 1979; 63(11-12):2047-8. PubMed ID: 526937
    [No Abstract]   [Full Text] [Related]  

  • 37. Phase II trial of Baker's antifol in patients with recurrent or inoperable head and neck cancer.
    Krasnow S; Green M; Perry DJ; Eisenberger MA; Johnston-Early A; Muggia F; Cohen MH
    Cancer Treat Rep; 1986 Aug; 70(8):1039-40. PubMed ID: 3524834
    [No Abstract]   [Full Text] [Related]  

  • 38. Phase II trial of aclarubicin in epidermoid carcinoma of the head and neck.
    Carugati AA; Olivari AJ; Campos DM; Pradier R; Woolley PV
    Cancer Treat Rep; 1986 Jun; 70(6):799-800. PubMed ID: 3524828
    [No Abstract]   [Full Text] [Related]  

  • 39. Phase II study of etoposide in previously untreated squamous cell carcinoma of the head and neck.
    Cobleigh MA; Hill JH; Lad TE; Shevrin DE; Applebaum EL
    Cancer Treat Rep; 1987 Mar; 71(3):321-2. PubMed ID: 3815398
    [No Abstract]   [Full Text] [Related]  

  • 40. Phase II evaluation of maytansine in patients with advanced head and neck cancer.
    Creagan ET; Fleming TR; Edmonson JH; Ingle JN
    Cancer Treat Rep; 1979; 63(11-12):2061-2. PubMed ID: 526939
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.